Opening book details…
About this nonfiction
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial by McGowan, Barbara M (author);Bruun, Jens M (author);Capehorn, Matt (author);Pedersen, Sue D (author);Pietiläinen, Kirsi H (author);Muniraju, Hanna Angelene Kudiyanur (author);Quiroga, Maria (author);Varbo, Anette (author);Lau, David C W (author) is a nonfiction available to read on EtoBox.
It is typically read by self-directed learners exploring a subject in depth.
Common subject areas: history, science, philosophy, social sciences.
- Author
- McGowan, Barbara M (author);Bruun, Jens M (author);Capehorn, Matt (author);Pedersen, Sue D (author);Pietiläinen, Kirsi H (author);Muniraju, Hanna Angelene Kudiyanur (author);Quiroga, Maria (author);Varbo, Anette (author);Lau, David C W (author)
- Publisher
- Elsevier BV
- Published
- 2024
- Language
- EN
- Category
- nonfiction
More by McGowan, Barbara M (author);Bruun, Jens M (author);Capehorn, Matt (author);Pedersen, Sue D (author);Pietiläinen, Kirsi H (author);Muniraju, Hanna Angelene Kudiyanur (author);Quiroga, Maria (author);Varbo, Anette (author);Lau, David C W (author)
Similar books
- Safety and Efficacy of Teriflunomide in Paediatric Multiple Sclerosis (TERIKIDS): a Multicentre, Double-blind, Phase 3, Randomised, Placebo-controlled Trial — Chitnis, Tanuja; Banwell, Brenda; Kappos, Ludwig; Arnold, Douglas L; Gücüyener, Kivilcim; Deiva, Kumaran; Skripchenko, Natalia; Cui, Li-Ying; Saubadu, Stephane; Hu, Wenruo; Benamor, Myriam; Le-Halpere, Annaig; Truffinet, Philippe; Tardieu, Marc; Dubois, Benedicte; Verhelst, Helene; Bojinova-Tchamova, Veneta; Mah, Jean; Cui, Li-Ying; Fang, Hao, Yunpeng; Jiang, Li; Ling; Mao, Ding'An; Qiu, Wei; Tan, Guojun; Wu, Ye; Zhang, Meini; Zhou, Hongyu; Zhou, Shuizhen; Gross-Paju, Katrin; Cheuret, Emmanuel; Deiva, Kumaran; Edan, Giles; Vukusic, Sandra; Chrousos, George; Zafeiriou, Dimitrios; Achiron, Anat; Vaknin-Dembinsky, Adi; Yamout, Bassem; Laurynaitiene, Jurate; Vaiciene-Magistris, Nerija; Bojkovski, Vladimir; Trajkova, Vesna; Chaouki, Sana; Kissani, Najib; Neuteboom, Rinze; Palavra, Filipe; Belova, Anna; Boyko, Alexey; Evdoshenko, Evgeny; Kairbekova, Ekaterina; Malkova, Nadezhda; Shumilina, Maria; Skripchenko, Natalya; Nikolic, Dimitrije; Meca-Lallana, Jose; Triki, Chahnez Charfi; Chokri, Mhiri; Gouider, Riadh; Anlar, Banu; Gücüyener, Kivilcim; Hiz, Ayse Semra; Idiman, Egemen; Turkoglu, Recai; Yapici, Zuhal; Yilmaz, Unsal; Tantsura, Lyudmyla; Voloshyna, Nataliia; Lim, Ming; Wassmer, Evangeline; Cascione, Mark; Chitnis, Tanuja; LaGanke, Christopher; Rathke, Kevin; Scagnelli, John (2021)
- Naltrexone 6 Mg Once Daily Versus Placebo in Women with Fibromyalgia: a Randomised, Double-blind, Placebo-controlled Trial — Due Bruun, Karin; Christensen, Robin; Amris, Kirstine; Vaegter, Henrik Bjarke; Blichfeldt-Eckhardt, Morten Rune; Bye-Møller, Lars; Holsgaard-Larsen, Anders; Toft, Palle (2023)
- Atosiban Versus Placebo for Threatened Preterm Birth (APOSTEL 8): a Multicentre, Randomised Controlled Trial — van der Windt, Larissa I; Klumper, Job; Duijnhoven, Ruben G; Kok, Marjolein; Ris-Stalpers, Carrie; de Boer, Marjon A; van Kaam, Anton H; Pajkrt, Eva; Mol, Ben W; Walker, Kate F; McAuliffe, Fionnuala M; van der Post, Joris A; Roos, Carolien; Oudijk, Martijn A; Schaaf, Jelle M; van Eyck, Jim; Knol, H Marieke; Sueters, Marieke; Scheepers, Liesbeth H C J; van der Ham, David P; van Laar, Judith O E H; van den Akker, Eline S A; Scholten, Ralph R; van Gemund, Nicolette; Vollebregt, Karlijn C; Visser, Harrie; Gordijn, Sanne J; Bekker, Mireille N; Langenveld, Josje (2025)
- Oral Semaglutide 50 Mg Taken Once Per Day in Adults with Overweight or Obesity (OASIS 1): a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial — Knop, Filip K; Aroda, Vanita R; do Vale, Ruben D; Holst-Hansen, Thomas; Laursen, Peter N; Rosenstock, Julio; Rubino, Domenica M; Garvey, W Timothy (2023)
- Safety and Efficacy of Once-weekly Efruxifermin Versus Placebo in Metabolic Dysfunction-associated Steatohepatitis (HARMONY): 96-week Results from a Multicentre, Randomised, Double-blind, Placebo-controlled, Phase 2b Trial — Prof Mazen Noureddin MD & Juan P Frias MD & Guy W Neff MD & K Jean Lucas MD & Cynthia Behling MD & Pierre Bedossa MD & Julie Dubourg MD & Doreen Chan PhD & Mark Burch PhD & Erica Fong BS & Brittany de Temple BS & Matt Minerva BS & Kim Barrett BS &... (2025)
- Semaglutide and Walking Capacity in People with Symptomatic Peripheral Artery Disease and Type 2 Diabetes (STRIDE): a Phase 3b, Double-blind, Randomised, Placebo-controlled Trial — Marc P Bonaca MD & Andrei-Mircea Catarig MD & Prof Kim Houlind MD & Prof Bernhard Ludvik MD & Prof Joakim Nordanstig MD PhD & Chethana Kalmady Ramesh MSc & Prof Neda Rasouli MD & Prof Harald Sourij MD MBA & Alex Videmark MD & Prof Subodh Verma MD PhD &... (2025)